Clinical Trials Browser

Phase 3 × Lymphoma × obinutuzumab × Clear all

NCT06191744 2026-05-06

EPCORE™FL-2

Phase 3 Recruiting

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT06084936 2026-05-04

GLOBRYTE

Phase 3 Recruiting

Lymphoma

NCT05929222 2025-12-24

FIL_GAZEBO

Phase 3 Recruiting

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

NCT01659099 2018-03-07

GAINED

Phase 3 Terminated

Disease, Lymphoma